col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


239 Results       Page 1

 [1] 
Elsevier: Vaccine X
  original article Date Title Authors   All Authors
1 [GO] 2025―Oct―28 Effectiveness of the 13-valent pneumococcal vaccine against hospitalized community-acquired pneumonia among adults ≥60 years in Madrid-Spain after the COVID-19 pandemic Maria Lahuerta, Angel Gil, Cristina Méndez, Francisco Javier Esteban Fernández, Teresa Álvarez de Espejo, Victor Julián Moreno, et al. (+12)
2 [GO] 2025―Oct―15 Effectiveness of 2023-2024 mRNA-1273 XBB.1.5 vaccine against COVID-19 associated hospitalizations and medically attended COVID-19 in the United States Zhe Zheng, Danielle MacCormac, Jennifer M. Radin, Tianyu Sun, Mitra Yousefi, Amanda Wilson, et al. (+9)
3 [GO] 2025―Sep―23 Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive, SARS-CoV-2-seropositive participants: A 6-month follow-up Katia Alves, Karen Kotloff, R. Scott McClelland, E. Adrianne Hammershaimb, Alex Kouassi, Joyce S. Plested, et al. (+9)
4 [GO] 2025―Sep―17 COVID-19 Vaccine Hesitancy Scale: Psychometric properties and validation among pregnant and breastfeeding persons and parents Heidi Sze Lok Fan, Edmond Pui Hang Choi, Elizabeth Keys, Rishma Chooniedass, Stephanie Masina, Alex Halonen, et al. (+2)
5 [GO] 2025―Sep―17 Factors associated with youth vaccine acceptance during the COVID-19 pandemic: Coordinated analyses across 5 Canadian datasets M.E. Ames, C.A. Sierra Hernandez, A.F. Chung, H. Elgharbawy, T.O. Afifi, S. Craig, et al. (+6)
6 [GO] 2025―Sep―08 Durability of neutralizing antibody and T-cell responses in COVID-19 patients after infection and booster vaccination Lin Yao, Xiao-Lin Jiang, Jun-Xia Cao, Qiang Guo, Meng-Na Wu, Shu-Zhi Wu, et al. (+13)
7 [GO] 2025―Sep―08 COVID-19 and influenza vaccination among adults stably engaged in HIV care Grazia Alessio, Drieda Zaçe, Christopher Jones, Andrea Di Lorenzo, Alessandra Imeneo, Vincenzo Malagnino, et al. (+5)
8 [GO] 2025―Sep―02 Understanding motivation and experience in participating in a paediatric SARS-CoV-2 serosurvey, in Australia Archana Koirala, Shayal A. Prasad, Philip N. Britton, Nicholas Wood, Peter C. Richmond, Brendan McMullan, et al. (+7)
9 [GO] 2025―Aug―18 The influence of partisanship on the roots of anti-vaccine attitudes in the context of the COVID-19 pandemic Sylvia Iasulaitis, Alan Demetrius Baria Valejo, Leonardo Ribeiro dos Santos
10 [GO] 2025―Aug―06 Reasons for unvaccinated booster dose of COVID-19, adverse reaction after vaccination, and COVID-19 infection status among those with COVID-19 booster vaccination hesitancy Sho Takahashi, Shohei Sakai, Yuichiro Ohki, Kaede Tobe, Yurie Kobashi, Masaharu Tsubokura
11 [GO] 2025―Jul―17 Immunogenicity of ARCT-154, a self-amplifying mRNA COVID-19 vaccine, in different booster settings Yoshiaki Oda, Nhan Thi Ho, Xuan-Hung Nguyen, Ly-Thi-Le Tran, Van Thu Nguyen, Yasuhiro Iwama, et al. (+9)
12 [GO] 2025―Jul―15 Changes in intentions, behavior, and reasons to receive COVID-19 vaccination December 2020-August 2023 Yanhan Shen, Kate Penrose, McKaylee M. Robertson, Laura Puzniak, Kristen E. Allen, Avantika Srivastava, et al. (+6)
13 [GO] 2025―Jun―25 Barriers to routine childhood vaccination during COVID-19: Lessons from a primary healthcare study in Greece Marinetta Bakea, Despoina Gkentzi, Chrysoula Perdikogianni, Eleni Vergadi
14 [GO] 2025―Jun―19 Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients Christopher W. Dukes, Junmin Whiting, Qianxing Mo, Christopher L. Cubitt, Barbara J. Kuter, Brett Leav, et al. (+4)
15 [GO] 2025―May―22 Corrigendum to “Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: A prospective single centre cohort study” [Vaccine:X 15 (2023) 100374] Dóra Dohos, Anna Karoliny, Eszter Gombos, Éva Rimanóczy, Katalin E. Müller
16 [GO] 2025―May―21 Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada Alison E. Simmons, Rafael N. Miranda, Michael W.Z. Li, Gebremedhin B. Gebretekle, Min Xi, Marina I. Salvadori, et al. (+7)
17 [GO] 2025―May―20 Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters Kabita Adhikari, Subhash C. Verma
18 [GO] 2025―May―01 Assessment of the impact of training tools on healthcare workers for PCV introduction in Maharashtra, India during the COVID-19 pandemic Syed Quadri, Pravin Vedpathak, Puskarr Deshmukkh, Arup Deb Roy, Abida Sultana, Amanjot Kaur, et al. (+4)
19 [GO] 2025―Apr―08 Household transmission of the SARS-CoV-2 omicron variant in New Zealand, 2022 Nayyereh Aminisani, Q. Sue Huang, Lauren Jelley, Timothy Wood, Tineke Jennings, Danielle Currin, et al. (+7)
20 [GO] 2025―Apr―08 Antibody response after SARS-CoV-2 infection or vaccination in China: A cross-sectional study Peng Zhu, Yan Chen, Xia Xu, Deyong Tan, Ledong Xiao, Chengling Liao, et al. (+11)
21 [GO] 2025―Apr―08 COVID-19 vaccination as a rare potential etiology for cause of death after medicolegal autopsy. A Finnish nationwide study. Lasse Pakanen, Tuomo Nieminen, Paula Kuvaja, Hanna Nohynek, Sirkka Goebeler, Miia Artama, Petteri Hovi
22 [GO] 2025―Mar―27 University Students' understanding of masking policies and their mask use in relation to COVID-19 vaccination history, both in and out of the classroom, during the pandemic, 2022-2023 Linda S. Gutierrez, Kate S. Brien, Walter Faig, Carmelita Whitfield, Susannah Anderson, Sarah Bauerle Bass, et al. (+3)
23 [GO] 2025―Mar―17 Reverse vaccinology-based multi-epitope COVID-19 vaccine targeting SARS-CoV-2 structural and non-structural proteins induces immune responses in mice Azzania Fibriani, Nicholas Yamahoki, Annisa Meliana Shani, Afifatur Rofiqoh, Agust Leo Fany Siregar, Cynthia Gunawan, et al. (+5)
24 [GO] 2025―Mar―13 Mid- and long-term mortality risk factors after COVID-19 hospitalization: A retrospective observational study in Peru Max Carlos Ramírez-Soto, Hugo Arroyo-Hernández
25 [GO] 2025―Mar―05 Evaluating the association between routine pneumococcal vaccination and COVID-19 severity among older adults in the United States: A case control study Ottavia Prunas, Andrew Tiu, Kayoko Shioda, Shweta Bansal, Daniel M. Weinberger
26 [GO] 2025―Feb―28 Using nationwide data to examine the relative effectiveness of Covid-19 vaccination against omicron amongst a population with low prior rates of SARS-CoV-2 infection: A cohort study J. Paynter, P. McIntyre, J. Wiki, N. Nghiem, B. Liu, L. Marek, M. Hobbs
27 [GO] 2025―Feb―25 Social networks, environmental, and individual factors associated with COVID-19 vaccination and booster uptake- The prospective PRIME cohort study Céline J.A. van Bilsen, Lisanne C.J. Steijvers, Stephanie Wagner, Demi M.E. Pagen, Senne M.C.E. Wijnen, Kevin Konings, et al. (+3)
28 [GO] 2025―Feb―22 COVID-19 vaccination hesitancy among hemodialysis patients: A mixed-methods study Yuka Sugawara, Masao Iwagami, Kan Kikuchi, Toyohiro Hashiba, Sayaka Yabushita, Risa Hara, et al. (+3)
29 [GO] 2025―Feb―17 ‘It's a shot, not a vaccine like MMR’: A new type of vaccine-specific scepticism on twitter/X during the COVID-19 pandemic Elena Semino, Tara Coltman-Patel, William Dance, Zsófia Demjén, Richard Gleave, Alison Mackey
30 [GO] 2025―Feb―06 Costs estimation of three models of COVID-19 vaccination in Beijing, China Hongzeng Wang, Dan Zhao, Xiaomei Li, Luodan Suo, Li Lu, Zhujiazi Zhang
31 [GO] 2024―Dec―19 Corrigendum to Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study Marciane Maria Rover, Fernando Luis Scolari, Geraldine Trott, Mariana Motta Dias da Silva, Denise de Souza, Rosa Da Rosa Minho Dos Santos, et al. (+41)
32 [GO] 2024―Dec―10 Medical mistrust and COVID-19 vaccine attitudes and behavior: Findings from a population-based cohort study in Michigan Soomin Ryu, Akash Patel, Kristi L. Allgood, Delvon T. Mattingly, Jana L. Hirschtick, Robert C. Orellana, Nancy L. Fleischer
33 [GO] 2024―Dec―05 Innate immune response after BNT162b2 COVID-19 vaccination associates with reactogenicity Catharina E. van Ewijk, Sara Suárez Hernández, Ronald Jacobi, Mirjam J. Knol, Susan Hahné, Alienke J. Wijmenga-Monsuur, et al. (+2)
34 [GO] 2024―Nov―25 Sociopolitical antecedents influencing COVID-19 vaccine uptake in Pima County, Arizona Sam Rodriguez, Kailey Haider, Famesh Patel, Grace Thatigiri, Benjamin Pope, Jasen Albana, et al. (+3)
35 [GO] 2024―Nov―15 Global COVID-19 vaccine hesitancy among elderly: A systematic review M.C. Law, P.K.F. Chiu
36 [GO] 2024―Nov―08 The cost-effectiveness of COVID-19 vaccination program among age-groups children, adults, and elderly in Europe: A systematic review T. Untung, R. Pandey, P. Johansson
37 [GO] 2024―Nov―07 COVID-19 vaccine or booster uptake and hesitancy for children aged 6 months-5 years in the United States: A national descriptive study using the household pulse survey between March and May 2023 Chulwoo Park, Pyramida Vagoyan Zabala
38 [GO] 2024―Nov―04 Association between vaccination and persistent COVID-19-related symptoms among patients with mild Omicron infection: A prospective cohort study Marciane Maria Rover, Fernando Luis Scolari, Geraldine Trott, Mariana Motta Dias da Silva, Denise de Souza, Rosa da Rosa Minho dos Santos, et al. (+41)
39 [GO] 2024―Oct―30 Trust in the science behind COVID-19 vaccines as a driver of vaccine acceptance in the United States, 2021-2023 Trenton M. White, Katarzyna Wyka, Kenneth Rabin, Ayman El-Mohandes
40 [GO] 2024―Oct―29 Social network characteristics of COVID-19 vaccination and preventive health behaviors: Cross-sectional findings from the US northeast during the early COVID-19 pandemic Aditya S. Khanna, Mollie A. Monnig, Samantha E. Clark, Peter M. Monti
41 [GO] 2024―Oct―25 COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature Su Hyun Lim, Mona Hersi, Ramya Krishnan, Joshua Montroy, Bonnie Rook, Kelly Farah, et al. (+8)
42 [GO] 2024―Oct―15 Pulmonary embolism after SARS-CoV-2 vaccination Björn Zethelius, Sofia Attelind, Gabriel Westman, Rickard Ljung, Anders Sundström
43 [GO] 2024―Oct―05 Sex differences in COVID-19 vaccine confidence in people living with HIV in Canada Jessica Lu, Branka Vulesevic, Ann N. Burchell, Joel Singer, Judy Needham, Yanbo Yang, et al. (+22)
44 [GO] 2024―Oct―02 Evaluation of vaccine perceptions in Israel’s Elderly: A Comparative study of COVID-19 and influenza vaccination attitudes Odai Abu Aid, Hanan Rohana, Maya Azrad, Avi Peretz
45 [GO] 2024―Sep―25 Social networks and COVID-19 vaccination intention in Dutch middle-aged and older adults in 2020: Insights into individual, interpersonal, community, and societal determinants - The SaNAE study Lisanne C.J. Steijvers, Céline J.A. van Bilsen, Stephanie Wagner, Sarah E. Stutterheim, Rik Crutzen, Robert A.C. Ruiter, et al. (+2)
46 [GO] 2024―Sep―25 Time-course analysis of antibody and cytokine response after the third SARS-CoV-2 vaccine dose Hyeon Hwa Kim, Hye Kyung Lee, Lothar Hennighausen, Priscilla A. Furth, Heungsup Sung, Jin Won Huh
47 [GO] 2024―Sep―25 Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults Geir Bredholt, Marianne Sævik, Hanne Søyland, Thor Ueland, Fan Zhou, Rishi Pathirana, et al. (+13)
48 [GO] 2024―Aug―12 Science-based exit from stringent countermeasures against COVID-19: Mortality prediction using immune landscape between 2021 and 2022 in Japan Taishi Kayano, Misaki Sasanami, Hiroshi Nishiura
49 [GO] 2024―Aug―06 COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review Oliver Galgut, Fiona Ashford, Alexandra Deeks, Andeep Ghataure, Mimia Islam, Tanvir Sambhi, et al. (+8)
50 [GO] 2024―Aug―03 Influenza virus strains expressing SARS-CoV-2 receptor binding domain protein confer immunity in K18-hACE2 mice Nathaniel A. Rader, Katherine S. Lee, Andrea N. Loes, Olivia A. Miller-Stump, Melissa Cooper, Ting Y. Wong, et al. (+4)
51 [GO] 2024―Aug―03 Safety pharmacology of human endogenous retrovirus-enveloped baculoviral DNA vaccines against SARS-CoV-2 in Sprague-Dawley rats and beagle dogs Sang-Jin Park, Joung-Wook Seo, Kang-Hyun Han, Byoung-Seok Lee, Chan Yeong Lee, Young Bong Kim, et al. (+2)
52 [GO] 2024―Jul―30 Comparison of anti-phospholipid antibody titers before and after SARS-CoV-2 mRNA vaccination in hospital staff Michi Hisano, Naho Morisaki, Makiko Sampei, Erika Obikane, Koushi Yamaguchi
53 [GO] 2024―Jul―27 Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study Anan Bzami, Changcheng Zhu, Marcus Estrada, Jessica A. White, Manjari Lal
54 [GO] 2024―Jul―27 Association of maternal infection of SARS-CoV-2 and neonatal susceptibility: A retrospective cohort study Xiao-Dan Zhu, Yan-Jie Peng, Ying Chen, Mei Xue, Ai-Juan Zhang, Yu Peng, et al. (+3)
55 [GO] 2024―Jul―18 Factors influencing parental COVID-19 vaccination willingness for children in Japan Mami Ueta, Alton Cao, Michio Murakami, Hana Tomoi, Stuart Gilmour, Keiko Maruyama-Sakurai, et al. (+10)
56 [GO] 2024―Jul―09 How stressful was the COVID-19 vaccination procedure? Comparison between mass vaccination centers and general practices Anne Schrimpf, Anne Jentzsch, Markus Bleckwenn, Anne-Kathrin Geier
57 [GO] 2024―Jul―05 Assessment of safety and adverse events following COVID-19 vaccination and their predictors in first 30 days among healthcare workers of a tertiary care teaching hospital in North India Abu Bashar, Bhushan Kamble, Sampath Kumar, Sanket V. Nandekar, Sharad Kumar Mathur
58 [GO] 2024―Jul―04 Mental health symptom associations with COVID-19 testing and vaccination among urban American Indian and Alaska Native people Cole Haskins, Carolyn Noonan, Richard MacLehose, Dedra Buchwald, Spero M. Manson
59 [GO] 2024―Jun―26 Effectiveness and duration of additional immune defense provided by SARS-CoV-2 infection before and after receiving the mRNA COVID-19 vaccine BNT162b2 Nagashige Shimada, Satoshi Sugawa, Satoshi Murakami, Masahiro Shinoda, Shinichiro Ota, Miwa Morikawa, et al. (+6)
60 [GO] 2024―Jun―22 Adverse events of COVID-19 vaccination during 2021-2022 suppressed by breakfast consumption and favorable sleeping habit among Japanese university students Nobuyuki Tetsuka, Keiko Suzuki, Kodai Suzuki, Takuma Ishihara, Takao Miwa, Satoko Tajirika, et al. (+4)
61 [GO] 2024―Jun―22 Lipodystrophy following Covid-19 Vaccination: A case report Mehrnaz Shakarami, Farnaz Sinaei, Bardiya Ghaderi Yazdi, Bentolhoda Ziaadini
62 [GO] 2024―Jun―22 Exploring COVID-19 vaccine hesitancy among young adults in Australia. A qualitative study Zachary Sum, Ernesta Sofija, Bernadette Sebar
63 [GO] 2024―Jun―21 Cost-effectiveness analysis of NVX-CoV2373 COVID-19 vaccination for elderly people in Japan Masafumi Kato, Takayori Ono, Hisato Deguchi, Norio Ohmagari, Ataru Igarashi
64 [GO] 2024―Jun―20 A phase 3, randomised, observer-blinded, placebo controlled-trial evaluating the safety and immunogenicity of investigational SARS-CoV-2 mRNA vaccine CVnCoV in adult healthcare workers in Mainz (Germany) Frank Kowalzik, Daniel Teschner, Margarida Mesquita, Christian Jensen, Daniel Schreiner, Kai Kronfeld, et al. (+10)
65 [GO] 2024―Jun―06 Impacts of COVID-19 vaccine boosters on clinical outcomes associated with the Omicron variant in China: A cross-sectional survey Haisu Feng, Jiayue Chen, Jiatong Sun, Yawen Jiang
66 [GO] 2024―May―18 The association of COVID-19 vaccination and menstrual health: A period-tracking app-based cohort study Malini Ramaiyer, Malak El Sabeh, Jiafeng Zhu, Amanda Shea, Dorry Segev, Gayane Yenokyan, Mostafa A. Borahay
67 [GO] 2024―May―12 SARS-CoV-2 vaccination in Canadian blood donors: Insight into donor representativeness of the general population Sheila F. O'Brien, Mindy Goldman, Behrouz Ehsani-Moghaddam, Wenli Fan, Lori Osmond, Chantale Pambrun, Steven J. Drews
68 [GO] 2024―May―03 Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium Pierre Hubin, Laura Van den Borre, Toon Braeye, Lisa Cavillot, Matthieu Billuart, Veerle Stouten, et al. (+5)
69 [GO] 2024―Apr―21 Antibody responses to SARS-CoV-2 spike protein in a cohort of renal transplant recipients following two-dose primary immunization - A Caribbean country’s perspective Lesley Roberts, Carla-Maria Alexander, Michele Monteil, Madhura Manjunath, Emile Mohammed, Valerie Wilson, Stefan Wilson
70 [GO] 2024―Apr―21 COVID-19 vaccine hesitancy prevalence in Mexico: A systematic review and metanalysis Diego Ramonfaur, Rupali J. Limaye, David E. Hinojosa-González, Francisco J. Barrera, Gloria P. Rodríguez-Gómez, Carlos Castillo-Salgado
71 [GO] 2024―Apr―19 Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations Naoki Tani, Hideyuki Ikematsu, Haruka Watanabe, Takeyuki Goto, Yuki Yanagihara, Yasuo Kurata, et al. (+5)
72 [GO] 2024―Apr―11 Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally Parisa A. ShamaeiZadeh, Carmen Villamizar Jaimes, Maria Deloria Knoll, Emmanuelle Espié, Rebecca E. Chandler
73 [GO] 2024―Mar―23 Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review Debendra Nath Roy, Nowrin Ferdiousi, Md. Mohabbot Hossen, Ekramul Islam, Md. Shah Azam
74 [GO] 2024―Mar―21 COVID-19 vaccine acceptance and associated determinants in Addis Ketema Sub-city, Addis Ababa, Ethiopia: A community-based study Genanew Kassie Getahun, Hailu Sefefe, Tewodros Shitemaw, Betselot Yirsaw Wubete
75 [GO] 2024―Mar―21 Factors associated with childhood non-vaccination against COVID-19 in Canada: A national survey analysis David Guan, Sailly Dave, Marwa Ebrahim, Julie A. Laroche
76 [GO] 2024―Mar―19 Vaccine hesitancy in adolescents regarding COVID-19 vaccination: A literature review Meita Dhamayanti, Rita Andriyani, Shycha Moenardi, Permata Putri Karina
77 [GO] 2024―Mar―14 A conceptual framework to model social determinants of COVID-19 vaccination uptake among underserved homeless populations Sahar Haidar, Thomas Roederer, Cécile Allaire, Bastien Mollo, Charline Vincent, Isabelle Bonmarin, et al. (+3)
78 [GO] 2024―Mar―13 Association of vaccination status and severity of SARS-CoV-2 infections in hospitalized patients Dubert Guerrero, Thomas Baker, Megan Corn, Sean Keup, Austin Nickell, Li Cao
79 [GO] 2024―Feb―27 Using machine learning algorithms to predict COVID-19 vaccine uptake: A year after the introduction of COVID-19 vaccines in Ghana Cornelius C. Dodoo, Ebo Hanson-Yamoah, David Adedia, Irene Erzuah, Peter Yamoah, Fareeda Brobbey, et al. (+2)
80 [GO] 2024―Feb―20 Determinants of vaccination decisions and lived experiences of Ghanaians with the COVID-19 pandemic; a qualitative study Lawrencia Aggrey-Bluwey, Gordon Abekah-Nkrumah
81 [GO] 2024―Feb―08 Association Between Vaccination Beliefs and COVID-19 Vaccine Uptake in a Longitudinal Panel Survey of Adults in the United States, 2021-2022 Elissa C. Kranzler, Joseph N. Luchman, Katherine A. Margolis, Timothy O. Ihongbe, Jae-Eun C. Kim, Benjamin Denison, et al. (+6)
82 [GO] 2024―Feb―02 Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: a systematic review and meta-regression analysis Joshua Nealon, Yonatan M Mefsin, Martina E. McMenamin, Kylie E. C. Ainslie, Benjamin J. Cowling
83 [GO] 2024―Feb―01 Attitudes and Practices to Adult Vaccination among physicians before and after COVID-19 pandemic in the United Arab Emirates Hiba J. Barqawi, Kamel A. Samara, Enad S Haddad, Layane M. Bakkour, Firas B. Amawi
84 [GO] 2024―Jan―31 Erratum to “Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: A self-controlled case series analysis” [Vaccine: X 15 (2023) 100418] Julia Stowe, Heather J. Whitaker, Nick J. Andrews, Elizabeth Miller
85 [GO] 2024―Jan―30 Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium Marina Digregorio, Pauline Van Ngoc, Simon Delogne, Eline Meyers, Ellen Deschepper, Nadia Dardenne, et al. (+11)
86 [GO] 2024―Jan―26 Researching childhood vaccine hesitancy in the wake of COVID-19 Alistair Anderson, Tom Douglass, Pru Hobson-West
87 [GO] 2024―Jan―24 SARS-CoV-2 vaccines in China could reduce COVID-19-related respiratory syndromes and deaths: A retrospective cohort study Weiping Yao, Yunhui Chen, Qiyu Huang, Wanxia Luo, Yueming Chen, Chuanbo Xie
88 [GO] 2024―Jan―21 Development of an RBD-Fc fusion vaccine for COVID-19 Yisheng Sun, Qiaomin Li, Yuanyuan Luo, Hanping Zhu, Fang Xu, Hangjing Lu, et al. (+4)
89 [GO] 2024―Jan―21 Parental gender influences their intention to HPV vaccinate their children, and the association between HPV and COVID-19 vaccination intentions Emiko Oka, Yutaka Ueda, Asami Yagi, Yuri Ito, Yoshihiko Hosokawa, Takahiro Tabuchi, Tadashi Kimura
90 [GO] 2024―Jan―21 Immunogenicity studies of recombinant RBD SARS-CoV-2 as a COVID-19 vaccine candidate produced in Escherichia coli Intan Aghniya Safitri, Yovin Sugijo, Fernita Puspasari, Fifi Fitriyah Masduki, Ernawati Arifin Giri-Rachman, Aluicia Anita Artarini, et al. (+2)
91 [GO] 2024―Jan―21 Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: a retrospective cohort study Jongmok Ha, Min Cheol Song, Suyeon Park, Hyunwook Kang, Taeeun Kyung, Namoh Kim, et al. (+8)
92 [GO] 2024―Jan―21 Effectiveness of Monovalent COVID-19 Booster/Additional Vaccine Doses in the United States J. Bradley Layton, Lauren Peetluk, Hui Lee Wong, Yixin Jiao, Djeneba Audrey Djibo, Christine Bui, et al. (+24)
93 [GO] 2024―Jan―20 Humoral immune response after SARS-CoV-2 vaccination in cladribine-treated multiple sclerosis patients M. Mimpen, D. Kreiter, T. Kempkens, S. Knippenberg, R. Hupperts, O. Gerlach
94 [GO] 2024―Jan―19 Maternal Worry of Children Contracting COVID-19 Predicts Vaccine Uptake in Young Children in Vermont Kristen Keene, Anupama Balsubramanian, Alexandra Potter, Leigh-Anne Cioffredi
95 [GO] 2024―Jan―17 Young adults’ intention to encourage COVID-19 vaccination among their grandparents: a nationwide cross-sectional survey of college students in China Zhihui Guo, Xinyi Li, Junye Bian, Weijie Zhang, Zhen Lu, Yinghui Sun, et al. (+3)
96 [GO] 2024―Jan―09 Overview of childhood vaccination coverage in Brazil and the impact of the COVID-19 pandemic: is our children’s health at risk? A review of pre-COVID-19 periods and during the COVID-19 pandemic Jéssica Paula Martins, Giulia Almeida Alatzatianos, Tais Mendes Camargo, Fernando Augusto Lima Marson
97 [GO] 2024―Jan―06 Effectiveness of the severe acute respiratory syndrome coronavirus 2 Omicron BA.5 bivalent vaccine on symptoms in healthcare workers with BA.5 infection Yosuke Hirotsu, Mika Takatori, Hitoshi Mochizuki, Masao Omata
98 [GO] 2023―Dec―07 Vicarious experiences of long COVID: A Protection Motivation Theory Analysis for Vaccination Intentions Eitze Sarah, Sprengholz Philipp, Korn Lars, Shamsrizi Parichehr, Felgendreff Lisa, Betsch Cornelia
99 [GO] 2023―Dec―02 Nationwide Safety Surveillance of COVID-19 mRNA vaccines following Primary Series and First Booster Vaccination in Singapore Dorajoo Sreemanee Raaj, Tan Hui Xing, Teo Chun Hwee Desmond, Neo Jing Wei, Koon Yen Ling, Ng Jing Jing Amelia, et al. (+10)
100 [GO] 2023―Dec―01 Risk of cardiac arrhythmia and cardiac arrest after primary and booster COVID-19 vaccination in England: a self-controlled case series analysis Julia Stowe, Heather J Whitaker, Nick J Andrews, Elizabeth Miller FMedSci
101 [GO] 2023―Nov―28 Impact of implemented vaccination strategies on vaccine uptake and attitude of final year pharmacy students toward COVID-19 vaccines in Gezira State, Sudan Alhumaira Wedaa, Mohamed Elmustafa, Hanaa A Babiker, Rana Ahmed
102 [GO] 2023―Nov―24 hybrid immunity from sars-cov-2 infection and mrna bnt162b2 vaccine among thai school-aged children Kanchanok Saraban, Piyarat Suntarattiwong, Napaporn Chantasrisawad, Sophida Boonsathorn, Pope Kosalaraksa, Wanatpreeya Phongsamart, et al. (+4)
103 [GO] 2023―Nov―22 Factors associated with COVID-19 vaccination among healthcare workers in an Algerian University Teaching Hospital: A cross-sectional study Abdessamad Dali-Ali, Imene Beneddine, Nori Midoun, Asmaa Oukebdane
104 [GO] 2023―Nov―19 Association of COVID-19 information media, providers, and content with vaccine uptake among Tokyo residents Noriko Noguchi, Ryosuke Yokoi, Taichi Masu, Masataka Watanabe, Sayoko Itoh, Sayumi Yumoto
105 [GO] 2023―Nov―18 Distinctions Between Survivors and Non-Survivors with SARS-CoV-2 Vaccine-Induced Thrombotic Thrombocytopenia: A Systematic Review and Meta-Analysis Alejandra Castro-Varela, Ana Karen Garza Salas, Alanna Barrios-Ruiz, Erick Ambriz Morales, Paulina Abascal-Lanzagorta, Maria Fernanda Reyes-Chavez, et al. (+6)
106 [GO] 2023―Nov―17 COVID-19 Vaccination and Infection among People with Self-Reported Chronic Health Conditions and Disabilities vs. People without Medical Risk Factors in a Survey Sample from Oslo Jessica Dimka
107 [GO] 2023―Nov―08 Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in Jordan Malik Sallam, Hiba Abbasi, Rawan J. Obeidat, Reham Badayneh, Farah Alkhashman, Aseel Obeidat, et al. (+3)
108 [GO] 2023―Nov―08 Effectiveness of COVID-19 vaccines in Ecuador: A test -negative design Francisco Pérez-Tasigchana, Ivette Valcárcel-Pérez, Maribel Arias-Quispe, Lucía Astudillo, Alfredo Bruno, Marco Herrera G., et al. (+10)
109 [GO] 2023―Nov―03 Influenza immunization of healthcare personnel in the post-COVID-19 pandemic era: still a lot to do! Caterina Ledda, Giuseppe Motta, Venerando Rapisarda, Helena C. Maltezou
110 [GO] 2023―Oct―27 Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial Akram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, Mohammadreza Ahi, Ali Sheidaei, Kimiya Gohari, et al. (+22)
111 [GO] 2023―Oct―12 Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis David Hakimian, Johnny Amer, Alaa Jammal, Asher Shafrir, Yael Milgrom, Mohammad Masarowah, et al. (+6)
112 [GO] 2023―Oct―05 Administration of an excessive dosage of covid-19 pfizer vaccine in an infant: case report of clinical and immune responses Jorgete Maria e Silva, Jhefferson Barbosa Guimarães, Soraya Regina Abu Jamra, Beatrice Santanastasio Mirante, Carlos Fabiano Capato, Daniel Macedo de Melo Jorge, Benedito Antônio Lopes da Fonseca
113 [GO] 2023―Sep―21 Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases Daidi Zhao, Wenting Zhang, Xue Ma, Runze Zhao, Lingling Yao, Jiarui Lu, et al. (+5)
114 [GO] 2023―Sep―20 An Online RCT on Behavioural Expectations Effects of COVID-19 Certification Policies in England Freya Mills, Holly Carter, Liza Benny, Matt Barnard, Charles Symons
115 [GO] 2023―Sep―20 Vaccination against COVID-19 and socioeconomic inequalities: a cross-sectional study in Ecuador Eulalia C. Torres, Maribel Moreno, María F. Rivadeneira
116 [GO] 2023―Sep―19 The Relationship Between Vaccine Acceptance and COVID-19 Mortality in Europe: A Cross-Country Analysis of Public Opinion and Epidemiological Data Stjepan Brnic, Bruno Buric, Robert Marcec, Robert Likic
117 [GO] 2023―Sep―16 Pregnant women’s attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: cross-sectional survey Samantha Kilada, Neil French, Elizabeth Perkins, Dan Hungerford
118 [GO] 2023―Sep―09 Assessing the potential impact of COVID-19 booster doses and oral antivirals: a mathematical modelling study of selected middle-income countries in the Indo-Pacific Gizem M. Bilgin, Kamalini Lokuge, Syarifah Liza Munira, Kathryn Glass
119 [GO] 2023―Sep―06 Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022 Beth Evans, Olivia Keiser, Laurent Kaiser, Thibaut Jombart
120 [GO] 2023―Sep―01 Longitudinal Long COVID Symptoms in Japanese Patients after COVID-19 Vaccinations Kensuke Nakagawara, Atsuho Morita, Ho Namkoong, Hideki Terai, Shotaro Chubachi, Takanori Asakura, et al. (+31)
121 [GO] 2023―Sep―01 Factors associated with COVID-19 vaccination in Belize Diego Rios-Zertuche, Giuliana Daga, Filippo Iorillo, Ana Mylena Aguilar Rivera, Melissa Diaz-Musa, Natalia Largaespada Beer, et al. (+2)
122 [GO] 2023―Aug―26 Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study Juan Hormazabal, Loreto Nuñez-Franz, Paola Rubilar, Mauricio Apablaza, Cecilia Vial, Lina Jimena Cortés, et al. (+7)
123 [GO] 2023―Aug―26 Disease severity of COVID-19 in different phases of the pandemic: Do healthcare workers have better outcomes? Xueying Yang, Fanghui Shi, Jiajia Zhang, Haoyuan Gao, Shujie Chen, Bankole Olatosi, et al. (+2)
124 [GO] 2023―Aug―19 Immunization of children with inflammatory bowel disease against SARS-CoV-19 infection: a prospective single centre cohort study Dóra Dohos, Anna Karoliny, Eszter Gombos, Éva Rimanóczy, Katalin E. Müller
125 [GO] 2023―Aug―18 COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration Abram L. Wagner, Felicia Zhang, Stefania Kerekes, Shu-Fang Shih, Lili Zhao
126 [GO] 2023―Aug―13 Low uptake of COVID-19 vaccines in Wad Medani City, Gezira State, Sudan: Hesitancy and poor accessibility M. Elmustafa, A. Wedaa, Hanaa Babiker, Ammar Elmajzoup, Halima Ali, Rana Ahmed
127 [GO] 2023―Aug―11 Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership Andrea A. Berry, Ashley H. Tjaden, Jone Renteria, DeAnna Friedman-Klabanoff, Amy N. Hinkelman, Michael A. Gibbs, et al. (+10)
128 [GO] 2023―Aug―09 COVID-19 vaccine eligibility of pregnant and lactating women in Bangladesh: Gap between policy and policy interpretation among policymakers and healthcare workers Rupali J. Limaye, Berhaun Fesshaye, Prachi Singh, Eleonor Zavala, Shirina Akter, Towfida Jahan Siddiqua, et al. (+3)
129 [GO] 2023―Aug―05 Immunogenicity of BNT162b2 in Children 6 Months to under 5 Years of Age with Previous SARS-CoV-2 Infection, in the Era of Omicron Predominance Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Orawan Himananto, Supawan Papakhee, Jiratchaya Sophonphan, et al. (+4)
130 [GO] 2023―Jul―27 Preventive knowledge, attitude, and vaccination challenges for COVID-19 among Myanmar refugees and irregular migrants in Malaysia Tual Sawn Khai, Muhammad Asaduzzaman
131 [GO] 2023―Jul―25 Vaccination against SARS-CoV-2 in a rural Ugandan population Joseph Mugisha, Bernard Mpairwe, Beatrice Kimono, Pontiano Kaleebu, Robert Newton
132 [GO] 2023―Jul―13 Global Equity and Timely Access: COVID-19 & Beyond 23rd DCVMN Annual General Meeting 2022 Report Rajinder Kumar Suri, Christina Liu, Aila Marini
133 [GO] 2023―Jul―08 Factors influencing Australian nursing and midwifery students COVID-19 vaccination intentions Abigail Ford, Penny Heidke, Chanchal Kurup, Lisa Wirihana, Jeremy Kroll, Pauline Calleja
134 [GO] 2023―Jul―07 Myocarditis following COVID-19 mRNA vaccinations: twin and sibling case series P Shenton, DR Cheng, P Simm, B Jones, NW Crawford
135 [GO] 2023―Jul―06 Routine vaccination for influenza and pneumococcal disease and its effect on COVID-19 in a population of Dutch older adults Esther J.M. Taks, Konstantin Föhse, Simone J.C.F.M. Moorlag, Jacobien Hoogerwerf, Reinout van Crevel, Cornelis H. van Werkhoven, et al. (+2)
136 [GO] 2023―Jul―01 Analyzing Factors Determining Vaccination Willingness against COVID-19 in Germany 2020 Caroline Dotter, Sonja Haug, Rainer Schnell, Anna Scharf, Amelie Altenbuchner, Karsten Weber
137 [GO] 2023―Jun―25 Attitudes toward annual COVID-19 boosters are highly structured by partisan self-identification and trust in government: Evidence from a longitudinal survey Filip Viskupič, David L. Wiltse
138 [GO] 2023―Jun―25 bDiabetes incidence before and after COVID-19 vaccination - Results from the German Disease Analyzer database Bernd Kowall, Karel Kostev, Rüdiger Landgraf, Hans Hauner, Ralf Bierwirth, Oliver Kuss, Wolfgang Rathmann
139 [GO] 2023―Jun―21 Long-term immunogenicity in previously vaccinated healthcare workers with inactivated virus vaccine after SARS-CoV-2 infection or booster vaccination Varalee Terbsiri, Opass Putcharoen, Gompol Suwanpimolkul, Watsamon Jantarabenjakul, Supaporn Wacharapluesadee, Nuntana Champa, et al. (+2)
140 [GO] 2023―Jun―20 Henoch-Schönlein purpura in a 6-year-old boy after initial COVID-19 vaccination Regina Célia de Souza Campos Fernandes, Daniela Vieira Nunes, Nathália Fragoso de Almeida, Nathalia da Cruz Assad Monteiro, Luiza Amanda Maron Pimenta, Enrique Medina-Acosta
141 [GO] 2023―Jun―10 Safety Profile of Inactivated COVID-19 Vaccine in Indonesian Adults Hindra Irawan Satari, Nastiti Kaswandani, Bernie Endyarni Medise, Julitasari Sundoro, Sri Rezeki Hadinegoro, Elcha Leonard, et al. (+2)
142 [GO] 2023―Jun―08 Choice Preference and Willingness to Pay for COVID-19 vaccination in Namibia Abisai Konstantinus, Iyaloo Konstantinus
143 [GO] 2023―Jun―07 The Assessment of Twitter Discourse on the New Covid-19 Variant, XBB.1.5, Through Social Network Analysis Ikhwan Yuda Kusuma, Hening Pratiwi, Shafa Fitri Khairunnisa, Dian Ayu Eka Pitaloka, Arie Arizandi Kurnianto
144 [GO] 2023―Jun―05 Critical Factors in the successful expansion of Pneumococcal Conjugate Vaccine in India during the COVID-19 pandemic Seema Singh Koshal, Arindam Ray, Rhythm Hora, Amanjot Kaur, Syed Quadri, Rashmi Mehra, et al. (+3)
145 [GO] 2023―Jun―02 Benefit-Risk Assessment Of Covid-19 Vaccine, MRNA (MRNA-1273) For Males Age 18-64 Years Osman N. Yogurtcu, Patrick R. Funk, Richard A. Forshee, Steven A. Anderson, Peter W. Marks, Hong Yang
146 [GO] 2023―May―27 Relapsing Myocarditis following Initial Recovery of post COVID-19 Vaccination in two Adolescent Males - Case reports Donato Amodio, Emma Manno, Nicola Cotugno, Veronica Santilli, Alessio Franceschini, Marco Alfonso Perrone, et al. (+7)
147 [GO] 2023―May―06 Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis Zainab Alimoradi, Malik Sallam, Elahe Jafari, Marc N. Potenza, Amir H. Pakpour
148 [GO] 2023―May―05 Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru Stephanie Montero, Diego Urrunaga-Pastor, Percy Soto-Becerra, Aleksandar Cvetkovic-Vega, Martina Guillermo-Roman, Luis Figueroa-Montes, et al. (+6)
149 [GO] 2023―Apr―28 Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189] Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, Carlos R. Celis, Rubelio Cornejo, Rodrigo DeAntonio, et al. (+17)
150 [GO] 2023―Apr―20 Differences in non-positive intention to accept the COVID-19 booster vaccine between three countries in the cross-border region Meuse-Rhine Euroregion: the Netherlands, Belgium, and Germany Céline JA van Bilsen, Christina Stabourlos, Chrissy PB Moonen, Stephanie Brinkhues, Stefaan Demarest, Daniëlle AT Hanssen, et al. (+6)
151 [GO] 2023―Apr―20 Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand Sayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, Kritsadee Rattanathammethee, Supachai Sakkhachornphop, Romanee Chaiwarith, et al. (+3)
152 [GO] 2023―Apr―19 Predictive factors of hesitancy to vaccination against SARS-CoV-2 virus in young adults in Spain: results from the PSY-COVID study Corel Mateo-Canedo, Juan Pablo Sanabria Mazo, Laura Comendador, Juan Sebastián Rojas, Meritxell Carmona, Neus Crespo Puig, et al. (+8)
153 [GO] 2023―Apr―17 Understanding the Factors that Influence Communication about COVID-19 Vaccines with Patients: perspectives of Australian Immunisation Providers Ikram Abdi, Katarzyna Bolsewicz, Bianca Bullivant, Mathew D. Marques, Maryke S. Steffens
154 [GO] 2023―Apr―11 Impact of vaccination on electrocardiograms of hospitalized patients for Covid-19 Marco Mele, Lucia Tricarico, Antonio Centola, Federica Mango, Andrea Favia, Francesca Croella, et al. (+7)
155 [GO] 2023―Apr―08 The Use of Health Belief Model (HBM) to Explain Factors Underlying People to Take the COVID-19 Vaccine in Indonesia Wignyo Adiyoso, Beti Nurbaiti, Firre An Suprapto
156 [GO] 2023―Apr―07 Trust and vaccine hesitancy during the COVID-19 pandemic: a cross-national analysis Will Jennings, Viktor Valgarðsson, Lawrence McKay, Gerry Stoker, Eduardo Mello, Hasan Muhammad Baniamin
157 [GO] 2023―Apr―04 COVID-19 Vaccination experience in patients with Rheumatoid Arthritis treated at a single VA Medical Center Sarah Abi Doumeth, Jenny Gong, Laura Silversteyn, Megan O'Mara, Shivali Singh, Donald D Anthony, Maya Mattar
158 [GO] 2023―Mar―30 COVID-19 Vaccine Uptake Trends in SARS-CoV-2 Previously Infected Cancer Patients Zainab Shahid, Alicia L Patrick, Michelle L Wallander, Erin E Donahue, Sally J Trufan, Antoinette R Tan, et al. (+8)
159 [GO] 2023―Mar―26 Acceptance or rejection of vaccination against influenza and SARS-CoV2 viruses among primary care professionals in Central Catalonia. A cross-sectional study Aïna Fuster-Casanovas, Josep Vidal-Alaball, Anna Bonet-Esteve, Raquel Muñoz-Miralles, Queralt Miró Catalina
160 [GO] 2023―Mar―25 Mix-and-match COVID-19 vaccines trigger high antibody response after the Third Dose Vaccine in Moroccan Health Care Workers Houda Amellal, Najlaa Assaid, Khadija Akarid, Abderrahmane Maaroufi, Sayeh Ezzikouri, M'hammed Sarih
161 [GO] 2023―Mar―23 Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire Hamed Hammoud, Soha S. Albayat, Jesha Mundodan, Saif Alateeg, Nada Adli, Doaa Sabir, et al. (+3)
162 [GO] 2023―Mar―17 Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history Kenji Ota, Satoshi Murakami, Kaori Ishihara, Daisuke Sasaki, Tetsuya Usui, Fujiko Mitsumoto-Kaseida, et al. (+14)
163 [GO] 2023―Mar―14 Systemic reactogenicity following homologues and heterologous prime-boost AZD1222 and BNT162b2 COVID-19 vaccination of 2862 healthcare workers compared with an unvaccinated population Sorosh Tabatabaeifar, Jesper M. Vestergaard, Else T. Würtz, Karoline K. Hansen, Kent J. Nielsen, Vivi Schlünssen, Henrik A. Kolstad
164 [GO] 2023―Feb―13 Psychosocial factors affecting COVID-19 vaccine uptake in the UK: a prospective cohort study (CoVAccS - wave 3) Louise E. Smith, Julius Sim, Megan Cutts, Hannah Dasch, Richard Amlôt, Nick Sevdalis, et al. (+2)
165 [GO] 2023―Feb―11 COVID-19 vaccination refusal and suspension of work among healthy healthcare personnel in Italy: a cross-sectional study of their knowledge and attitudes toward vaccinations Caterina Ledda, Venerando Rapisarda, Helena C. Maltezou
166 [GO] 2023―Feb―11 Who is Getting Boosted; Disparities in COVID-19 Vaccine Booster Uptake Among Health Care Workers Wigdan Farah, Laura Breeher, Caitlin Hainy, Christopher P. Tommaso, Melanie D. Swift
167 [GO] 2023―Feb―11 The burden of COVID-19 in French Guiana: vaccine-averted deaths, hospitalizations and costs Mathieu Nacher, Nicolas Vignier, Cyril Rousseau, Antoine Adenis, Maylis Douine, Célia Basurko, et al. (+9)
168 [GO] 2023―Feb―11 Culture of Vaccine Acceptability or Resistance: The Curious Case of Chile’s COVID-19 Vaccine Rollout a Great Example and Anthropology’s Role in Increasing Vaccination Inayat Ali
169 [GO] 2023―Jan―23 Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses Valentina Yurina, Oktavia Rahayu Adianingsih, Nashi Widodo
170 [GO] 2023―Jan―18 Nationalism, Conspiracy Theories and Vaccine Mandates: Exploring the Statism Determinants for Attitudes to COVID-19 Control in China Ruifen Zhang, Jun Yan, Hepeng Jia, Xi Luo, Jingke Lin, Qinliang Liu
171 [GO] 2023―Jan―07 COVID-19 vaccine hesitancy among health workers in rural Uganda: a mixed methods study Patrick Diox Ouni, Racheal Namulondo, Benon Wanume, David Okia, Peter Olupot Olupot, Ritah Nantale, et al. (+5)
172 [GO] 2022―Dec―28 Acute adverse events of Sars-CoV2 vaccines: Experiences from a health care worker vaccination campaign in two municipal hospitals in Northwest Germany Pawel Kermer, Yasser Abdalla, Guido Klein, Claus Lüers
173 [GO] 2022―Dec―22 Conception and reality: outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments Tamás Resál, Mária Matuz, Csilla Keresztes, Péter Bacsur, Kata Szántó, Anett Sánta, et al. (+10)
174 [GO] 2022―Dec―15 COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetes Marjan Doppen, Ali Mirjalili, Matire Harwood, Allie Eathorne, Irene Braithwaite, Jonathan Bong, et al. (+10)
175 [GO] 2022―Dec―13 Factors of influenza vaccine inoculation and non-inoculation behavior of community-dwelling residents in Japan: suggestions for vaccine policy and public health ethics after COVID-19 Mayuko T. Komada, Jung Su Lee, Etsuko Watanabe, Eisuke Nakazawa, Katsumi Mori, Akira Akabayashi
176 [GO] 2022―Nov―25 “I’m scared that if I have the vaccine, it’s going to make my lung condition worse, not better.” COVID-19 vaccine acceptance in adults with underlying health conditions - a qualitative investigation Maryke S Steffens, Bianca Bullivant, Catherine King, Katarzyna Bolsewicz
177 [GO] 2022―Nov―21 Drivers of COVID-19 vaccine hesitancy among women of childbearing age in Victoria, Australia: A descriptive qualitative study J. Oliver, j. Kaufman, k. Bagot, Z. Bradfield, C. Homer, K.B. Gibney, M. Danchin
178 [GO] 2022―Nov―17 Reactogenicity and immunogenicity of the intradermal administration of BNT162b2 mRNA vaccine in healthy adults who were primed with an inactivated SARS-CoV-2 vaccine Yutthapong Temtanakitpaisan, Suchaorn Seangnipanthkul, Nataporn Sarakosol, Sasinapa Maskasem, Siwawoot Mongkon, Benjaporn Buranrat, et al. (+3)
179 [GO] 2022―Nov―16 Spirituality and religiosity contribute to ongoing COVID-19 vaccination rates: Comparing 195 regions around the world Jason P. Martens, Bastiaan T. Rutjens
180 [GO] 2022―Nov―09 COVID-19 Vaccination in Africa: A Case of Unsatisfied Expectation and ill-Preparedness Osmond C. Ekwebelem, Phemelo Tamasiga, Abdullahi Tunde Aborode, Ismaeel Yunusa, Uju Nwauzoma, Helen Onyeaka
181 [GO] 2022―Nov―08 COVID-19 Site Readiness Initiative: Building Clinical Trial Capacity for Vaccine Efficacy Trials in Latin America in Response to the Pandemic Sue Ann Costa Clemens, Ana Keiko Sekine, Fernanda Tovar-Moll, Ralf Clemens
182 [GO] 2022―Nov―03 Factors associated with COVID-19 vaccine intention in Benin in 2021: A cross-sectional study Elias Martinien Avahoundje, Jean-Paul Dossou, Armelle Vigan, Ibrahima Gaye, Christian Agossou, Christelle Boyi, et al. (+5)
183 [GO] 2022―Oct―19 Intramuscular injection of a mixture of COVID-19 peptide vaccine and tetanus vaccine in horse induced neutralizing antibodies against authentic virus of SARS-CoV-2 Delta variant Weiwen Deng, Raymond W. Sweeney
184 [GO] 2022―Oct―19 Trends and factors associated with change in COVID-19 vaccination intent among residents and staff in six Seattle homeless shelters, March 2020 to August 2021 Sarah N. Cox, Julia H. Rogers, Nicholas B. Thuo, Ashley Meehan, Amy C. Link, Natalie K. Lo, et al. (+7)
185 [GO] 2022―Oct―19 Massachusetts flu vaccination and application for COVID-19 routine vaccination planning Megan Hatch, R. Monina Klevens
186 [GO] 2022―Oct―17 Pharmacy deserts and COVID-19 risk at the census tract level in the State of Washington Rachel Wittenauer, Parth D. Shah, Jennifer L. Bacci, Andy Stergachis
187 [GO] 2022―Oct―06 Use of financial incentives to increase adult vaccination coverage: a narrative review of lessons learned from COVID-19 and other adult vaccination efforts Nina Schwalbe, Layth Hanbali, Marta C. Nunes, Susanna Lehtimaki
188 [GO] 2022―Oct―03 No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19 Naoki Tani, Hideyuki Ikematsu, Takeyuki Goto, Kei Gondo, Yuki Yanagihara, Yasuo Kurata, et al. (+8)
189 [GO] 2022―Sep―30 Immunogenicity to SARS-CoV-2 Omicron variant among school-aged children with 2-dose of inactivated SARS-CoV-2 vaccines followed by BNT162b2 booster Napaporn Chantasrisawad, Thanyawee Puthanakit, Katesiree Kornsitthikul, Peera Jaru-Ampornpan, Monta Tawan, Pariya Matapituk, et al. (+4)
190 [GO] 2022―Sep―29 Trust is the common denominator for COVID-19 vaccine acceptance: a literature review Bipin Adhikari, Phaik Yeong Cheah, Lorenz von Seidlein
191 [GO] 2022―Aug―30 A Qualitative Study of COVID-19 Vaccine Decision Making Among Urban Native Americans Anna E. Epperson, Savanna L. Carson, Andrea Garcia, Alejandra Casillas, Yelba Castellon-Lopez, Arleen F. Brown, Nanibaa' A. Garrison
192 [GO] 2022―Aug―29 Heterologous Prime-boost of SARS-CoV-2 Inactivated Vaccine and mRNA BNT162b2 among Healthy Thai Adolescents Thanyawee Puthanakit, Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Jiratchaya Sophonphan, Thutsanun Meepuksom, et al. (+4)
193 [GO] 2022―Aug―22 Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study Md Mohsin, Sultan Mahmud, Ashraf Uddin Mian, Prottay Hasan, Abdul Muyeed, Md. Taif Ali, et al. (+6)
194 [GO] 2022―Aug―18 Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine Bhawna Sharma, C. Sarai Racey, Amy Booth, Arianne Albert, Laurie W. Smith, Anna Gottschlich, et al. (+7)
195 [GO] 2022―Aug―06 Acceptability of COVID-19 vaccines among Black immigrants living in the United States Adedotun Ogunbajo, Bisola O. Ojikutu
196 [GO] 2022―Aug―05 Major considerations in vaccinating children in Africa against COVID-19 Oluwanifemi Williams Osakuade, Ngusha Victory Anyam
197 [GO] 2022―Aug―03 Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses Laura Padula, Eva Fisher, Katelyn Rivas, Kristin Podack, Daniela Frasca, Jonah Kupritz, et al. (+5)
198 [GO] 2022―Jul―28 Advance Market Commitments (AMC) model application for Colombian purchase strategy of COVID-19 vaccines Espinosa Oscar, Rodríguez Jhonathan, Robayo Adriana, Arregocés Leonardo, Agudelo Nicolás, Suárez Carolina, et al. (+3)
199 [GO] 2022―Jul―27 Prevalence of parents' non-intention to vaccinate their children and adolescents against COVID-19: a comparative analysis in Colombia and Peru Vicente A. Benites-Zapata, Percy Herrera-Añazco, Jerry K. Benites-Meza, Karen Bonilla-Aguilar, Diego Urrunaga-Pastor, Guido Bendezu-Quispe, et al. (+3)
200 [GO] 2022―Jul―11 Geographical Variation of COVID-19 Vaccination Coverage, Ethnic Diversity and Population Composition in Flanders C. Faes, G. Molenberghs, N. Hens, L. Van Bortel, N. Vandeboel, K. Pellens, et al. (+3)
201 [GO] 2022―Jul―01 Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: a phase 2 randomized study Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, Carlos R Celis, Rubelio Cornejo, Rodrigo DeAntonio, et al. (+17)
202 [GO] 2022―Jun―21 Willingness to be vaccinated against COVID-19 is equal in individuals with affective disorders and healthy controls Frederike T. Fellendorf, Nina Bonkat, Martina Platzer, Elena Schönthaler, Michaela Ratzenhofer, Susanne A. Bengesser, et al. (+2)
203 [GO] 2022―Jun―18 Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: prospective cohort study from a hospital in Argentina A. Gentile, V.E. Castellano, A. Pacchiotti, N. Weinberger, S. Diana Menéndez, M. del Pino, et al. (+3)
204 [GO] 2022―Jun―18 SARS-CoV-2 Variants and Pregnant Women: A Cause for Concern? Joy Onyinyechi Chionuma, Helen Onyeaka, Osmond C. Ekwebelem, Nnabueze Darlington Nnaji
205 [GO] 2022―Jun―14 Understandings and Practices Related to Risk, Immunity and Vaccination During the Delta Variant COVID-19 Outbreak in Australia: An Interview Study Deborah Lupton
206 [GO] 2022―Jun―13 COVID-19 Vaccine Hesitancy and Influential Factors among Thai Parents and Guardians to Vaccinate Their Children Amornphat Kitro, Wachiranun Sirikul, Ekkamon Dilokkhamaruk, Gowgeat Sumitmoh, Sarisa Pasirayut, Amnart Wongcharoen, et al. (+3)
207 [GO] 2022―Jun―08 Anti-spike protein antibody responses to BNT162b2 mRNA vaccine: a single-center survey in a COVID-19 non-epidemic area in Japan Sho Mokuda, Namiki Kawanishi, Shintaro Kuroshima, Junko Kono, Hirofumi Nakayama, Hiroshi Mieno, Masashi Kawamoto
208 [GO] 2022―Jun―07 Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: a Cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2 Naiara Parraza-Diez, Cristina Bermudez-Ampudia, Raquel Cobos-Campos, Ines Garmendia, Estibalitz Orruño, Elena Ojeda, et al. (+4)
209 [GO] 2022―Jun―07 SARS-CoV-2 Antibody response after BNT162b2 mRNA vaccine in healthcare workers: nine-month of follow-up Franco Mastroianni, Pietro Guida, Grazia Bellanova, Edy Valentina De Nicolò, Giulia Righetti, Maurizio Formoso, Fabrizio Celani
210 [GO] 2022―May―31 Vaccination policies for healthcare personnel in the COVID-19 era: current challenges and future perspectives Helena C. Maltezou, George Dounias, Venerando Rapisarda, Caterina Ledda
211 [GO] 2022―May―18 COVID-19 vaccine acceptance and its determinants: a cross-sectional study among the socioeconomically disadvantaged communities living in Delhi, India Yadlapalli S. Kusuma, Shashi Kant
212 [GO] 2022―May―02 Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2 José L Casado, Pilar Vizcarra, Johannes Haemmerle, Héctor Velasco, Adrián Martín-Hondarza, Mario J. Rodríguez-Domínguez, et al. (+5)
213 [GO] 2022―Apr―29 Predicting COVID-19 Vaccine Hesitancy in Hong Kong: Vaccine Knowledge, Risks from Coronavirus, and Risks and Benefits of Vaccination Stephanie Jean Tsang
214 [GO] 2022―Apr―23 COVID-19 Vaccine Hesitancy and Intent in California Registered Nurses Linda Vuong, Julie T. Bidwell, Ester Carolina Apesoa-Varano, Fawn A. Cothran, Sheryl L. Catz
215 [GO] 2022―Mar―19 Impact of covid-19 pandemic on vaccination against meningococcal C infection in Brazil Thales Philipe Rodrigues da Silva, Leyla Gabriela Verner Amaral Brandão, Ed Wilson Rodrigues Vieira, Thalita Beatriz Santos Maciel, Tércia Moreira Ribeiro da Silva, Bianca Maria Oliveira Luvisaro, et al. (+2)
216 [GO] 2022―Mar―19 “Get a shot of rhythm and blues”: songs on Corona and COVID-19 vaccination Ger T. Rijkers, Olivier Braas
217 [GO] 2022―Mar―11 Global interest in vaccines during the COVID-19 pandemic: evidence from Google Trends Aida Khakimova, Leila abdollahi, Oleg Zolotarev, Rahim Fakher
218 [GO] 2022―Mar―08 Low Prevalence of COVID-19 Vaccine Hesitancy in Students Across Health Science Disciplines in Texas Meredith G. Hosek, Autumn B. Chidester, Jonathan Gelfond, Barbara S. Taylor
219 [GO] 2022―Mar―05 Comparison of Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom, Sompong Sapsutthipas, et al. (+6)
220 [GO] 2022―Feb―25 COVID-19 susceptibility and vaccination coverage for measles, rubella and mumps in students and healthcare workers in Trieste Hospitals (NE Italy) Eleonora Cattaruzza, Lucia Radillo, Federico Ronchese, Corrado Negro, Francesca Rui, Paola De Michieli, Francesca Larese Filon
221 [GO] 2022―Feb―24 COVID-19 and cancelled vaccination programs: Forecasting outbreaks of vaccine preventable diseases (VPDs) in Pakistan Inayat Ali
222 [GO] 2022―Feb―19 Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: A qualitative study David Lessard, David Ortiz-Paredes, Hyejin Park, Olivia Varsaneux, James Worthington, Nicole E. Basta, et al. (+5)
223 [GO] 2022―Jan―31 Medical Factors Associated with Caregiver Intention to Vaccinate their Children Against COVID-19 Thao-Ly T. Phan, Paul T. Enlow, Michael K. Wong, Amanda M. Lewis, Anne E. Kazak, Jonathan M. Miller
224 [GO] 2022―Jan―05 Explaining the intention to uptake COVID-19 vaccination using the Behavioral and Social Drivers of Vaccination (BeSD) model Subburaj Alagarsamy, Sangeeta Mehrolia, Ushanandini Pushparaj, S Jeevananda
225 [GO] 2021―Dec―28 Cov19VaxKB: A Web-based Integrative COVID-19 Vaccine Knowledge Base Philip C. Huang, Rohit Goru, Anthony Huffman, Asiyah Yu Lin, Michael F. Cooke, Yongqun He
226 [GO] 2021―Dec―22 Reduced COVID-19 Hospitalizations among New York City Residents Following Age-Based SARS-CoV-2 Vaccine Eligibility: Evidence from a Regression Discontinuity Design Sharon K. Greene, Alison Levin-Rector, Emily McGibbon, Jennifer Baumgartner, Katelynn Devinney, Alexandra Ternier, et al. (+3)
227 [GO] 2021―Nov―05 Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice Chih-Yun Lai, Albert To, Teri Ann S. Wong, Michael M. Lieberman, David E. Clements, James T. Senda, et al. (+7)
228 [GO] 2021―Nov―03 Appendicitis as a possible safety signal for the COVID-19 vaccines Joseph Mitchell, Qun-Ying Yue
229 [GO] 2021―Oct―22 To be or not to be vaccinated against COVID-19 - The adolescents’ perspective - A mixed-methods study in Sweden S. Nilsson, J. Mattson, M. Berghammer, A-L. Brorsson, M. Forsner, M. Jenholt Nolbris, et al. (+7)
230 [GO] 2021―Sep―08 The successful COVID-19 vaccine rollout in Chile: factors and challenges Claudio Castillo, Pablo Villalobos Dintrans, Matilde Maddaleno
231 [GO] 2021―Sep―03 COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria Obi Peter Adigwe
232 [GO] 2021―Jul―15 Willingness to vaccinate against Covid-19: A qualitative study involving older adults from Southern Switzerland Marta Fadda, L. Suzanne Suggs, Emiliano Albanese
233 [GO] 2021―Jun―29 Intentions of Public School Teachers in British Columbia, Canada to Receive a COVID-19 Vaccine C. Sarai Racey, Robine Donken, Imogen Porter, Arianne Albert, Julie A. Bettinger, Jennifer Mark, et al. (+9)
234 [GO] 2021―Apr―24 Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein Jillian M. DiMuzio, Baron C. Heimbach, Raymond J. Howanski, John P. Dowling, Nirja B. Patel, Noeleya Henriquez, et al. (+9)
235 [GO] 2021―Apr―20 Seasonal Influenza Vaccination Policies in the 194 WHO Member States: the evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access Kathleen F. Morales, David W. Brown, Laure Dumolard, Claudia Steulet, Alba Vilajeliu, Alba Maria Ropero Alvarez, et al. (+3)
236 [GO] 2021―Apr―01 Cancelled routine vaccination appointments due to COVID-19 pandemic in Germany Nora Katharina Schmid-Küpke, Dorothea Matysiak-Klose, Anette Siedler, Lisa Felgendreff, Lothar Wieler, Heidrun M. Thaiss, Cornelia Betsch
237 [GO] 2021―Mar―23 Demographic, psychological, and experiential correlates of SARS-CoV-2 vaccination intentions in a sample of Canadian families Christine L. Lackner, Charles H. Wang
238 [GO] 2021―Jan―12 Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: an example using rotavirus vaccines applied to SARS-CoV-2 T Christopher Mast, David Heyman, Erik Dasbach, Craig Roberts, Michelle Goveia, Lyn Finelli
239 [GO] 2020―Aug―28 What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV2? Marc Hellerstein
 [1] 

239 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec